Mednax IncFind Ratings Reports
MEDNAX INC's gross profit margin for the second quarter of its fiscal year 2016 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased. MEDNAX INC has strong liquidity. Currently, the Quick Ratio is 1.58 which shows the ability to cover short-term cash needs. The company's liquidity has increased from the same period last year, indicating improving cash flow.
During the same period, stockholders' equity ("net worth") has increased by 15.24% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY16||Q2 FY15|
|Net Sales ($mil)||771.76||676.59|
|Net Income ($mil)||82.43||84.13|
|Balance Sheet||Q2 FY16||Q2 FY15|
|Cash & Equiv. ($mil)||62.48||70.43|
|Total Assets ($mil)||4771.41||4275.14|
|Total Debt ($mil)||1439.45||1296.9|
|Profitability||Q2 FY16||Q2 FY15|
|Gross Profit Margin||33.71||33.83|
|Return on Assets||6.99||7.65|
|Return on Equity||13.04||14.75|
|Debt||Q2 FY16||Q2 FY15|
|Share Data||Q2 FY16||Q2 FY15|
|Shares outstanding (mil)||93.5||94.03|
|Div / share||0.0||0.0|
|Book value / share||27.36||23.61|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||567242.0||761695.0|
BUY. This stock's P/E ratio indicates a discount compared to an average of 20.87 for the Health Care Providers & Services industry and a discount compared to the S&P 500 average of 25.30. For additional comparison, its price-to-book ratio of 2.36 indicates a discount versus the S&P 500 average of 2.83 and a discount versus the industry average of 3.23. The price-to-sales ratio is similar to the S&P 500 average, but it is significantly above the industry average, indicating a premium. Upon assessment of these and other key valuation criteria, MEDNAX INC proves to trade at a discount to investment alternatives within the industry.
|MD 18.04||Peers 20.87||MD 15.39||Peers 12.68|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
MD is trading at a discount to its peers.
Premium. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
MD is trading at a premium to its peers.
|MD 14.17||Peers 16.00||MD 1.16||Peers 0.85|
Average. An average price-to-projected earnings ratio can signify an industry neutral stock price and average future growth expectations.
MD is trading at a valuation on par with its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
MD trades at a significant premium to its peers.
|MD 2.36||Peers 3.23||MD 6.23||Peers 26.83|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
MD is trading at a significant discount to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, MD is expected to significantly trail its peers on the basis of its earnings growth rate.
|MD 2.02||Peers 0.78||MD 15.24||Peers 14.20|
Premium. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
MD is trading at a significant premium to its industry.
Average. Comparing a company's sales growth to its industry helps to determine if the company is adding or losing market share.
MD is keeping pace with its peers on the basis of sales growth.